Stocks and Investing Stocks and Investing
Tue, August 22, 2023
Mon, August 21, 2023

Jeff Johnson Maintained (TNDM) at Hold with Decreased Target to $32 on, Aug 21st, 2023


Published on 2024-10-28 06:02:34 - WOPRAI, Jeff Johnson
  Print publication without navigation


Jeff Johnson of Baird, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Hold with Decreased Target from $33 to $32 on, Aug 21st, 2023.

Jeff has made no other calls on TNDM in the last 4 months.



There are 6 other peers that have a rating on TNDM. Out of the 6 peers that are also analyzing TNDM, 2 agree with Jeff's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Larry Biegelsen of "Wells Fargo" Maintained at Hold with Decreased Target to $30 on, Friday, August 4th, 2023
  • Jayson Bedford of "Raymond James" Downgraded from Buy to Hold on, Monday, April 24th, 2023


These are the ratings of the 4 analyists that currently disagree with Jeff


  • Matt Miksic of "Barclays" Maintained at Buy with Decreased Target to $62 on, Monday, August 7th, 2023
  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $34 on, Friday, August 4th, 2023
  • Alexander Nowak of "Craig-Hallum" Maintained at Strong Buy with Decreased Target to $50 on, Tuesday, June 13th, 2023
  • Travis Steed of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $33 on, Friday, May 5th, 2023

Contributing Sources